- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03379714
Mid-term Data Collection of the Treatment of Intracranial Aneurysms With the WEB™ Aneurysm Embolization System
Data Collection of the Treatment of Intracranial Aneurysms With the WEB™ Aneurysm Embolization System: a Monocentric Post-market Observational Study
Study Overview
Status
Intervention / Treatment
Study Type
Contacts and Locations
Study Locations
-
-
Antwerp
-
Edegem, Antwerp, Belgium, 2650
- University hospital Antwerp
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient is at least 18 years old.
- Patient is capable to undergo general anaesthesia.
- Patient must sign and date the informed consent form prior to data registration. If patient is not able to give informed consent for himself/herself, a legally authorized representative must give informed consent on his/her behalf.
- Patient has a ruptured or unruptured intracranial aneurysm requiring endovascular treatment.
- Aneurysm with dome-to-neck ratio ≥ 1.
- Aneurysm size favourable for WEB implantation (aneurysm width < 10 mm or aneurysm width > 3mm).
Exclusion Criteria:
- Patient is pregnant.
- Patient has renal insufficiency (GRF < 45 ml/min/1.73 m2).
- Patient is unable to comply with the study protocol (e.g. no permanent address, known to be non-compliant or presenting an unstable psychiatric history).
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients with ruptured or unruptured intracranial aneurysms
|
The WEB aneurysm embolization system is a class III device and consists of an implantable embolization device attached to a delivery device.
The WEB is a mesh composed of single layers of braided nitinol tubes with platinum cores.
The braids are held together by proximal and distal platinum/ iridium radiopaque markers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Determination of anatomic outcome
Time Frame: at 6 months
|
grade of occlusion of the aneurysm assessed by MRA WEB Occlusion Scale: WOS A: complete occlusion WOS B: complete occlusion with opacification of the proximal recess WOS C: residual neck filling WOS D: residual aneurysm filling |
at 6 months
|
Determination of anatomic outcome
Time Frame: at 24 months
|
grade of occlusion of the aneurysm assessed by MRA WEB Occlusion Scale: WOS A: complete occlusion WOS B: complete occlusion with opacification of the proximal recess WOS C: residual neck filling WOS D: residual aneurysm filling |
at 24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Determination of procedural complications (Adverse events) during the operation
Time Frame: during index-procedure
|
Procedural complications: aneurysm rupture, dissection, thromboembolic events (symptomatic and non-symptomatic), device protrusion through the neck of the aneurysm inside the parent artery, detachment problem, device stuck in microcatheter, bleeding.
|
during index-procedure
|
Recording the use of additional devices during treatment.
Time Frame: during index-procedure
|
Possible additional devices are stent, coils, flow diverter
|
during index-procedure
|
Determination of the occurrence of post-procedural symptomatic thromboembolic events
Time Frame: up to 24 months follow-up
|
up to 24 months follow-up
|
|
Determination of clinical outcome: assessing disability of the patient by the modified Rankin Scale (mRS)
Time Frame: At baseline
|
0 - No symptoms.
|
At baseline
|
Determination of clinical outcome: assessing disability of the patient by the modified Rankin Scale (mRS)
Time Frame: at 6 to 8 weeks follow-up
|
0 - No symptoms.
|
at 6 to 8 weeks follow-up
|
Determination of clinical outcome: assessing disability of the patient by the modified Rankin Scale (mRS)
Time Frame: at 6 months follow-up
|
0 - No symptoms.
|
at 6 months follow-up
|
Determination of clinical outcome: assessing disability of the patient by the modified Rankin Scale (mRS)
Time Frame: at 24 months follow-up
|
0 - No symptoms.
|
at 24 months follow-up
|
Fisher grade (severity of intracranial SAH) for ruptured aneurysms.
Time Frame: at baseline
|
Fisher grade: 1 No haemorrhage evident. 2 Subarachnoid haemorrhage less than 1mm thick. 3 Subarachnoid haemorrhage more than 1mm thick. 4 Subarachnoid haemorrhage of any thickness with intraventricular haemorrhage (IVH) or parenchymal extension. |
at baseline
|
Determination of technical success of the device
Time Frame: during index-procedure
|
Technical success is defined as device deployment in the target aneurysm as intended by the investigator with adequate occlusion of the aneurysm (WOS A, B or C).
|
during index-procedure
|
Determination of overall mortality
Time Frame: up to 24 months
|
up to 24 months
|
|
Recording of intracranial haemorrhage during follow-up
Time Frame: up to 24 months
|
up to 24 months
|
|
Recording the need for re-intervention during follow-up.
Time Frame: up to 24 months
|
up to 24 months
|
|
Hunt and Hess scale (severity of clinical effect of SAH) for ruptured aneurysms.
Time Frame: baseline
|
Hunt and Hess scale:
|
baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Maurits Voormolen, Prof Dr, Study Principal Investigator
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MTS-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ruptured and Unruptured Intracranial Aneurysms
-
Medical Therapy SolutionsArcher ResearchTerminatedRuptured and Unruptured Intracranial AneurysmsBelgium
-
Zhujiang HospitalSecond Affiliated Hospital, School of Medicine, Zhejiang University; Xuanwu... and other collaboratorsUnknownUnruptured Intracranial Aneurysms | Ruptured Intracranial Aneurysms | Stent-Assisted Coiling | Non-Stent-Assisted Coiling | Craniotomy ClippingChina
-
Shape Memory Medical, Inc.Active, not recruitingRuptured or Unruptured Cerebral AneurysmsChile
-
Fondation Ophtalmologique Adolphe de RothschildActive, not recruitingIntracranial Aneurysms | Ruptured AneurysmFrance
-
Universitätsmedizin MannheimUMC Utrecht; University of Hamburg-Eppendorf; KKS Netzwerk; Schwiete Stiftung,...UnknownUnruptured Intracranial AneurysmsNetherlands, Germany
-
Johann Wolfgang Goethe University HospitalDepartment of Neurosurgery, Goethe-University Frankfurt am Main; Institute...CompletedUnruptured Intracranial AneurysmsGermany
-
CHU de ReimsCompletedUnruptured Intracranial AneurysmsFrance
-
Vascular Neurology of Southern California Inc.RecruitingAneurysm | Subarachnoid Hemorrhage, Aneurysmal | Intracranial Aneurysm | Ruptured Aneurysm | Cerebral Aneurysm UnrupturedUnited States
-
Pulsar VascularTerminatedUnruptured Wide-neck Intracranial AneurysmsUnited States
-
University Hospitals Cleveland Medical CenterCompletedCerebral Aneurysm Unruptured | Cerebral Aneurysm RupturedUnited States
Clinical Trials on WEB aneurysm embolization system
-
Microvention-Terumo, Inc.CompletedBrain AneurysmFrance, Germany, Hungary
-
Microvention-Terumo, Inc.Completed
-
Medical Therapy SolutionsArcher ResearchTerminatedRuptured and Unruptured Intracranial AneurysmsBelgium
-
Microvention-Terumo, Inc.Completed
-
Microvention-Terumo, Inc.UnknownIntracranial Aneurysms | Wide Neck Bifurcation Intracranial AneurysmsUnited States, Denmark, Canada, Hungary, Germany, Turkey
-
Microvention-Terumo, Inc.Unknown
-
Shenzhen Baoan District People's HospitalActive, not recruitingAneurysm | Subarachnoid Hemorrhage | Brain SwellingChina
-
Microvention-Terumo, Inc.CompletedIntracranial AneurysmDenmark, France, Germany, Hungary
-
Vanderbilt University Medical CenterStryker NeurovascularActive, not recruiting
-
Vascular Neurology of Southern California Inc.RecruitingAneurysm | Subarachnoid Hemorrhage, Aneurysmal | Intracranial Aneurysm | Ruptured Aneurysm | Cerebral Aneurysm UnrupturedUnited States